Americold Realty Trust (COLD)
$21.75 -$0.08 (-0.39%) 8:00 AM 11/19/24
NYSE | $USD | REIT - IndustrialStock Data
-
Market Cap
$6.22B -
Day's Range
$21.67 - $21.96 -
Volume
2,621,020 -
52 Week Low / High
$21.51 - $30.22 -
PE Ratio
- -
PEG Ratio
4.03 -
Dividend Frequency
quarterly
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 6
- Strong Buy
- 4
- Buy
- 4
- Hold
- 0
- Sell
- 0
- Strong Sell
- $35.30
- Target Price
Company News
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
North Texas pulls off upset of cold-shooting Minnesota — Nov 14th, 2024
Rondel Walker recorded 14 points and three steals and North Texas led nearly the entire way while notching a 54-51 victory over Minnesota on Wednesday in nonconference play at Minneapolis....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
Ukraine's mortar shell production surge stymied by explosives shortage — Nov 1st, 2024
Ukraine has increased production of mortar shells from zero before Russia's invasion to millions per year now, but a global explosives shortage is constraining the push to ramp up the weapons industry, Kyiv's top arms official said....
-
North Texas pulls off upset of cold-shooting Minnesota — Nov 14th, 2024
Rondel Walker recorded 14 points and three steals and North Texas led nearly the entire way while notching a 54-51 victory over Minnesota on Wednesday in nonconference play at Minneapolis....
-
Ukraine's mortar shell production surge stymied by explosives shortage — Nov 1st, 2024
Ukraine has increased production of mortar shells from zero before Russia's invasion to millions per year now, but a global explosives shortage is constraining the push to ramp up the weapons industry, Kyiv's top arms official said....
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
North Texas pulls off upset of cold-shooting Minnesota — Nov 14th, 2024
Rondel Walker recorded 14 points and three steals and North Texas led nearly the entire way while notching a 54-51 victory over Minnesota on Wednesday in nonconference play at Minneapolis....
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
North Texas pulls off upset of cold-shooting Minnesota — Nov 14th, 2024
Rondel Walker recorded 14 points and three steals and North Texas led nearly the entire way while notching a 54-51 victory over Minnesota on Wednesday in nonconference play at Minneapolis....
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
North Texas pulls off upset of cold-shooting Minnesota — Nov 14th, 2024
Rondel Walker recorded 14 points and three steals and North Texas led nearly the entire way while notching a 54-51 victory over Minnesota on Wednesday in nonconference play at Minneapolis....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
Ukraine's mortar shell production surge stymied by explosives shortage — Nov 1st, 2024
Ukraine has increased production of mortar shells from zero before Russia's invasion to millions per year now, but a global explosives shortage is constraining the push to ramp up the weapons industry, Kyiv's top arms official said....
-
Ukraine's mortar shell production surge stymied by explosives shortage — Nov 1st, 2024
Ukraine has increased production of mortar shells from zero before Russia's invasion to millions per year now, but a global explosives shortage is constraining the push to ramp up the weapons industry, Kyiv's top arms official said....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
North Texas pulls off upset of cold-shooting Minnesota — Nov 14th, 2024
Rondel Walker recorded 14 points and three steals and North Texas led nearly the entire way while notching a 54-51 victory over Minnesota on Wednesday in nonconference play at Minneapolis....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
Ukraine's mortar shell production surge stymied by explosives shortage — Nov 1st, 2024
Ukraine has increased production of mortar shells from zero before Russia's invasion to millions per year now, but a global explosives shortage is constraining the push to ramp up the weapons industry, Kyiv's top arms official said....
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
U.S. FDA proposes ending use of popular decongestant present in cold medicines — Nov 7th, 2024
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
US accuses Russia, China of shielding North Korea at UN — Nov 4th, 2024
The United States on Monday called out Russia and China at the United Nations Security Council for "shamelessly protecting" and emboldening North Korea to further violate U.N. sanctions as Pyongyang pledged to accelerate building up its "nuclear force."...
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
-
Canada approves GSK's RSV vaccine for adults aged 50 to 59 — Nov 5th, 2024
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age group....
Portfolio
Comprised of 1 portfolios